BNR
Burning Rock Biotech
49 hedge funds and large institutions have $67.1M invested in Burning Rock Biotech in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.56% less ownership
Funds ownership: 3.38% → 2.82% (-0.56%)
76% less capital invested
Capital invested by funds: $274M → $67.1M (-$207M)
Holders
49
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.3M | |
| 2 | +$5.57M | |
| 3 | +$2.87M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.42M |
| 5 |
Barclays
London,
United Kingdom
|
+$2.31M |
Top Sellers
| 1 | -$24.9M | |
| 2 | -$14.1M | |
| 3 | -$5M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$4.19M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$4.08M |